The focus of the company is the development, demonstration of clinical benefit, and early-stage commercialization of cryotherapy systems for the treatment of coronary plaque.
Location: Belgium, Liège, Awans
Employees: 1-10
Total raised: $36.78M
Founded date: 2009
Investors 4
| Date | Name | Website |
| - | Earlybird ... | earlybird.... |
| - | Creathor V... | creathor.c... |
| - | Peppermint... | pvp.health |
| - | High-Tech ... | htgf.de |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 18.02.2022 | - | $13.98M | - |
| 03.07.2019 | Series B | $8M | - |
| 07.07.2016 | Series B | $5.75M | Creathor V... |
| 06.05.2014 | - | $9.05M | - |
Mentions in press and media 9
| Date | Title | Description |
| 18.02.2022 | CryoTherapeutics receives additional funding of € 12.3 million and launches a new clinical study | Awans, Belgium, 17 February 2022 - CryoTherapeutics, focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatmentof coronary artery disease th... |
| 03.07.2019 | CryoTherapeutics Closes €7M Series B Financing Round | CryoTherapeutics, a Cologne, Germany-based and Awans, Belgium-based developer of cryotherapy systems for the treatment of coronary plaque, closed a €7m Series B equity, debt and grant financing. Backers included Noshaq (formerly Meusinvest)... |
| 27.06.2019 | German medtech startup CryoTherapeutics raises €7 million to prevent heart attacks | Heart disease is the leading cause of death for both men and women. Potsdam-based CryoTherapeutics is developing a cryotherapy system – a treatment that exposes the body to freezing temperatures – to prevent heart attacks. Founded in 2009, ... |
| 07.07.2016 | CryoTherapeutics Rraises €5.2M in Series B Financing | CryoTherapeutics, a Potsdam, Germany-based developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease, raised €5.2m a Series B financing. The round was led by Creathor Venture, with participation from ... |
| 06.05.2014 | CryoTherapeutics Raises Funding; Brings Series A to €6.5M | CryoTherapeutics GmbH, a Cologne, Germany-based developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease, completed an extension to its Series A financing bringing the total of the round to €6.5m. Th... |
| 21.03.2013 | CryoTherapeutics Raises Additional Series A Funding | CryoTherapeutics GmbH, a German developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease, completed a second closing of its Series A financing round. This investment brings the total of the Series A ... |
| - | Creathor Venture leads a Series B financing round of € 5.2 million in CryoTherapeutics | Creathor Venture, one of the leading European Venture Capital firms, leads a Series B financing round in CryoTherapeutics, the developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease. The Life Scien... |
| - | CryoTherapeutics closes Series B financing round at EUR 7 million | Awans, Belgium and Cologne, Germany – CryoTherapeutics GmbH and CryoTherapeutics SA today announced the closing of its B round of financing. The funding will be used to support the Company’s clinical trials programme and to establish operat... |
| - | CryoTherapeutics | “USING CRYOTHERAPY TO TREAT AND PREVENT HEART ATTACKS” |